°

The immunologist warned against a premature introduction of the vaccine from COVID-19

Before introducing a vaccine against coronavirus, it is necessary to complete the third phase of testing involving thousands of people to ensure its efficacy and safety for different groups of the population, the vaccine can't risk it, as do healthy people, said in an interview with RIA Novosti Israeli immunologist Professor Jacob Berman.

The Russian direct investment Fund (RDIF) has pending applications for registration in Russia in the first vaccine against coronavirus COVID-19 within 10 days, said on Monday the head of RDIF Kirill Dmitriev. According to him, all the procedures by the Ministry of health will be observed. The results of the first and second phases of the test are good.

If the first vaccinations started to do the test in March, by this time young and healthy people who received the first vaccine, there are only three or four months that, according to experts, is not enough. "And the third phase for this. When it for a longer period and children and the sick, and people with some underlying diseases. And watching them and watching. If they start to do a mass vaccination, it is necessary to closely monitor people. And to turn this mass vaccination would be a continuation of the study," added Berman.

According to the Professor, any failure with the vaccine, the problems with its safety or effectiveness can lead to an increase in antiprivivochnaya movement and outbreaks of disease, considered as already conquered.

Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.